paralytic strabismus: An ocular deviation caused by a palsy to one or more of the extraocular muscles or nerves supplying them. [database_cross_reference: ORCID:0000-0003-0986-4123][database_cross_reference: ORCID:0000-0003-0986-4123]
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2695 |
4. Check minimum number of eventsNone |
2695 |
5. Include endpoints |
2846 |
6. Filter based on genotype QC (FinnGen only) |
2745 |
Control definitions (FinnGen only)
- Control exclude
- H7_OCUMUSCLE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H49-H52
- Name in latin
- Strabismus paralyticus
Similar endpoints
↥List of similar endpoints to
Paralytic strabismus
based on the number of shared cases.
Similar with more cases:
- Strabismus
- Disorders of ocular muscles, binocular movement, accommodation and refraction
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 18942 | 9349 | 9495 |
| Only index persons | 16522 | 8232 | 8290 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.27 | 0.27 | 0.27 |
| Only index persons | 0.31 | 0.30 | 0.32 |
| Median age at first event (years) | |||
| Whole population | 61.07 | 61.75 | 60.34 |
| Only index persons | 60.55 | 61.10 | 60.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2745 | 1385 | 1360 |
| Unadjusted period prevalence (%) | 0.56 | 0.49 | 0.62 |
| Median age at first event (years) | 61.14 | 58.55 | 63.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2846
- Matched controls
- 28460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
11348.3
307.7
826
*
H53.2
ICD-10 Finland
Diplopia
59.6
307.7
1098
297
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
8534.1
307.7
670
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
16384.0
307.7
1270
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.3
296.0
729
1736
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.1
293.1
585
1152
AA1AD
NOMESCO Finland
CT of head and brain
3.2
191.4
1238
5556
XCK00
NOMESCO Finland
Perimetry
5.3
179.7
400
853
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.0
176.2
249
336
H50.2
ICD-10 Finland
Vertical strabismus
310.6
172.9
174
6
CE2W4
NOMESCO Finland
Eye movement mapping
83.5
167.8
89
11
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.1
146.2
464
1302
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
141.6
774
3070
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
15.0
131.1
117
81
CEC00
NOMESCO Finland
Recession of extraocular muscle
1262.3
125.0
121
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
109.1
104
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
959.8
95.5
93
*
3785A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Paralytic strabismus
+∞
95.3
91
*
37304
ICD-8 Finland
Strabismus, paralyticus. Paresis nervorum III, IV, VI
+∞
91.1
87
*
TAB00
NOMESCO Finland
Lumbar puncture
4.4
88.5
234
566
G35
ICD-10 Finland
Multiple sclerosis
8.9
87.3
110
128
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
12.5
78.9
78
64
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
15.8
78.7
68
44
G51.0
ICD-10 Finland
Bell palsy
5.4
78.5
160
311
H50.52
ICD-10 Finland
Exophoria
27.3
74.6
51
19
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
10.2
73.9
84
85
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.3
73.8
127
210
109
Kela drug reimbursment
Multiple sclerosis
9.9
70.9
82
85
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
8.5
70.0
91
110
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.8
70.0
394
1540
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
11.5
68.3
71
63
R51.80
ICD-10 Finland
Headache
2.4
63.2
509
2359
G70.0
ICD-10 Finland
Myasthenia gravis
16.7
60.8
51
31
H49.9
ICD-10 Finland
Paralytic strabismus, unspecified
+∞
60.6
58
*
H02.4
ICD-10 Finland
Ptosis of eyelid
4.5
60.3
153
357
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
58.7
427
1886
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
10.5
57.1
63
61
N07AA02
ATC
pyridostigmine; systemic
13.1
56.3
54
42
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
5.3
54.9
113
221
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.0
53.4
256
912
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
13.4
52.9
50
38
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
6.5
51.7
85
134
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
+∞
51.2
49
*
B01AC04
ATC
clopidogrel; oral
2.1
49.7
597
3228
A10AB05
ATC
insulin aspart; parenteral
2.6
48.7
300
1218
108
Kela drug reimbursment
Myasthenia gravis
16.9
47.9
40
24
A10AC01
ATC
insulin (human); parenteral
2.6
47.1
299
1231
H50.1
ICD-10 Finland
Divergent concomitant strabismus
244.0
47.1
48
*
CEW99
NOMESCO Finland
Other operation on extraocular muscle
465.2
46.4
46
*
H53.1
ICD-10 Finland
Subjective visual disturbances
2.8
45.7
239
891
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.2
43.9
91
179
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.3
43.9
172
543
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.5
43.5
154
456
A10AE04
ATC
insulin glargine; parenteral
2.3
43.3
355
1641
H50.30
ICD-10 Finland
Intermittent esotropy
152.4
42.9
45
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
42.3
1234
8747
CS494
NOMESCO Finland
Other visual field testing
4.0
42.3
123
318
CEC30
NOMESCO Finland
Resection of extraocular muscle
+∞
40.7
39
*
XCK10
NOMESCO Finland
Photography of fundus of eye
2.3
39.7
343
1619
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.6
39.1
50
59
N86
ICPC
Multiple sclerosis
10.9
39.1
42
39
H49.8
ICD-10 Finland
Other paralytic strabismus
+∞
38.6
37
*
L03AB07
ATC
interferon beta-1a; parenteral
10.1
38.1
43
43
H02.2
ICD-10 Finland
Lagophthalmos
11.3
37.1
39
35
A10AA02, ,
ATC
3.4
37.0
139
427
A10AB01
ATC
insulin (human); parenteral
3.4
36.9
135
408
H3603, E103,
ICD-10 Finland
7.3
36.9
54
75
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
8.4
36.9
48
58
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
36.8
1365
10186
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.4
36.8
137
419
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.0
35.7
102
260
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
13.9
35.7
33
24
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.1
35.3
98
245
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.2
35.1
146
478
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
34.9
273
1233
H50.9
ICD-10 Finland
Strabismus, unspecified
79.2
34.9
39
5
H3601, E103,
ICD-10 Finland
7.7
33.6
47
62
T90.5
ICD-10 Finland
Sequelae of intracranial injury
5.6
33.3
63
114
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.5
33.0
81
184
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
5.5
32.4
63
117
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.7
32.2
60
107
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.4
32.2
229
991
H50.8
ICD-10 Finland
Other specified strabismus
320.6
31.9
32
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
5.9
31.8
57
98
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
7.1
31.8
48
69
H52.1
ICD-10 Finland
Myopia
5.5
31.8
61
112
H50.51
ICD-10 Finland
Esophoria
88.6
31.8
35
*
A10AA01, ,
ATC
3.7
31.5
101
280
S06.2
ICD-10 Finland
Diffuse brain injury
6.3
31.3
53
86
H47.2
ICD-10 Finland
Optic atrophy
10.7
31.3
34
32
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
30.9
205
859
H49.4
ICD-10 Finland
Progressive external ophthalmoplegia
+∞
30.3
29
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
30.3
29
*
R42
ICD-10 Finland
Dizziness and giddiness
1.7
30.2
671
4332
L03AX13
ATC
glatiramer acetate; parenteral
11.1
30.2
32
29
A10AB04
ATC
insulin lispro; parenteral
3.3
30.1
115
357
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
5.8
29.8
54
94
H50.31
ICD-10 Finland
Intermittent exotropia
104.5
28.7
31
*
PA6AD
NOMESCO Finland
CT of neck arteries
3.2
28.7
115
368
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.6
28.5
97
280
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
27.9
559
3499
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
27.7
807
5574
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
8.6
27.5
35
41
F05
ICPC
Visual disturbance other
3.1
27.4
114
373
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
7.2
27.1
40
56
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
5.6
26.6
50
90
H46
ICD-10 Finland
Optic neuritis
6.5
26.5
43
67
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
25.8
199
891
H47.1
ICD-10 Finland
Papilloedema, unspecified
7.6
25.5
36
48
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
6.2
25.4
43
70
ZXA10
NOMESCO Finland
Bilateral
1.7
25.2
528
3338
3503
FHL
Single muscle retroposition
+∞
25.0
24
*
SPAT1301
SPAT
No procedures
1.6
24.9
868
6222
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.5
24.8
60
135
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.1
24.7
260
1318
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
24.7
710
4864
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4.3
24.6
63
148
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.3
24.6
36
50
S06.3
ICD-10 Finland
Focal brain injury
4.6
24.5
58
128
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.5
24.3
47
87
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
29.4
24.1
32
11
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
+∞
24.0
23
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
6.9
23.3
36
53
H36.01
ICD-10 Finland
Diabetic maculopathy
4.2
23.3
61
146
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
8.9
23.3
29
33
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
22.9
257
1333
T89
ICPC
Diabetes insulin dependent
2.7
22.8
129
500
H52.2
ICD-10 Finland
Astigmatism
6.3
22.7
38
61
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
22.7
786
5604
AAF00
NOMESCO Finland
Ventriculostomy
6.5
22.6
37
58
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.1
22.6
95
313
H3601, E113,
ICD-10 Finland
3.7
22.1
69
188
A10AE05
ATC
insulin detemir; parenteral
2.3
22.0
175
794
H50.4
ICD-10 Finland
Other and unspecified heterotropia
+∞
21.9
21
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
21.3
707
4982
SPAT1229
SPAT
Assessment of need for aid
2.0
20.9
245
1290
G91.0
ICD-10 Finland
Communicating hydrocephalus
6.9
20.8
32
47
CKC12
NOMESCO Finland
Photocoagulation of retina
2.5
20.6
131
538
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
6.4
20.5
34
54
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.5
20.5
137
575
L04AX01
ATC
azathioprine; systemic
2.6
20.5
125
503
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.0
20.5
91
310
C10AA01
ATC
simvastatin; oral
1.5
20.1
1201
9520
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
20.1
486
3173
H36.00
ICD-10 Finland
Diabetic background retinopathy
4.0
20.0
56
141
XA800
NOMESCO Finland
Neuropsychological investigation
2.5
20.0
129
533
N03AX16
ATC
[U] pregabalin
1.6
19.8
623
4327
CEC20
NOMESCO Finland
Recession and advancement of extraocular muscle
+∞
19.8
19
*
H53.4
ICD-10 Finland
Visual field defects
3.3
19.4
74
230
C10AA05
ATC
atorvastatin; oral
1.4
19.4
1155
9132
SPAT1262
SPAT
Handing over of treatment supplies
1.6
19.4
502
3331
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.5
19.3
67
196
A10AD01
ATC
insulin (human); parenteral
3.4
19.2
69
207
ZXD05
NOMESCO Finland
Urgent procedure
1.5
18.9
810
6000
H04AA01
ATC
glucagon; nasal, parenteral
3.4
18.7
68
205
Z3231
NOMESCO Finland
Registered nurse
1.5
18.4
730
5319
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
18.3
83
286
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
3.6
18.2
60
170
H3603, E113,
ICD-10 Finland
4.4
18.0
45
104
CKC15
NOMESCO Finland
Panretinal photocoagulation
4.6
18.0
42
92
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.8
17.9
54
144
E23.00
ICD-10 Finland
Panhypopituitarism
7.6
17.8
25
33
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
7.3
17.8
26
36
N02BE01
ATC
paracetamol; systemic, rectal
1.6
17.8
2430
22294
L04AX07
ATC
dimethyl fumarate; oral
13.8
17.7
30
22
353
Kela drug reimbursment
Cladribine and fingolimod
22.9
17.7
25
11
164
Kela drug reimbursment
Fingolimod
20.2
17.7
26
13
37300
ICD-8 Finland
Strabismus, Concomitans convergens
+∞
17.7
17
*
CEC80
NOMESCO Finland
Partial transposition of extraocular muscle
+∞
17.7
17
*
SPAT1263
SPAT
Sampling
1.4
17.7
1080
8533
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
5.2
17.7
36
70
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
17.7
890
6788
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
15.7
17.5
28
18
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
17.4
380
2412
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
5.4
17.3
34
64
C08CA01
ATC
amlodipine; oral
1.4
17.1
1061
8394
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.5
17.0
103
414
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
7.2
17.0
25
35
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
16.8
445
2962
T90
ICPC
Diabetes non-insulin dependent
1.5
16.3
653
4753
J01DB01
ATC
cefalexin; oral
1.5
16.2
2196
19816
G91.1
ICD-10 Finland
Obstructive hydrocephalus
6.6
16.2
26
40
SPAT1153
SPAT
Removal of sutures
1.4
16.1
843
6452
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
6.0
16.0
28
47
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
47.8
16.0
19
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.3
15.9
59
181
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
15.7
772
5837
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
15.6
15
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
15.6
62
198
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
6.0
15.6
27
45
H02AB09
ATC
hydrocortisone; systemic
2.9
15.6
71
246
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
15.5
238
1366
H57.1
ICD-10 Finland
Ocular pain
2.5
15.5
96
390
WX140
NOMESCO Finland
Parabulbar anesthesy
2.1
15.4
144
697
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
15.4
581
4170
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
14.8
15.3
25
17
S02.10
ICD-10 Finland
Fracture of base of skull, closed
7.0
15.3
23
33
N18
ICPC
Paralysis/weakness
2.9
14.9
70
247
N03AX12
ATC
[U] gabapentin; oral
1.6
14.9
420
2831
H3600, E103,
ICD-10 Finland
4.3
14.8
38
90
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
14.8
989
7876
G52.8
ICD-10 Finland
Disorders of other specified cranial nerves
57.0
14.8
17
*
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.4
14.7
105
455
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.4
14.7
100
424
SPAT1312
SPAT
General health counselling
1.4
14.7
780
5970
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
14.6
709
5336
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
14.6
1662
14401
H49.3
ICD-10 Finland
Total (external) ophthalmoplegia
+∞
14.6
14
*
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
+∞
14.6
14
*
A02BC02
ATC
pantoprazole; systemic
1.4
14.5
1791
15711
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
14.5
228
1318
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.4
14.5
28
52
H52.0
ICD-10 Finland
Hypermetropia
4.6
14.5
34
75
ZXC95
NOMESCO Finland
Use of surgical navigator
3.7
14.4
45
123
N03AX14
ATC
levetiracetam; systemic
2.6
14.4
84
332
N28
ICPC
Limited function/disability (N)
3.1
14.3
60
198
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
14.2
144
719
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.3
13.9
103
454
A10BA02
ATC
metformin; oral
1.4
13.9
768
5908
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.7
13.9
75
285
L04AA27
ATC
[U] fingolimod
17.6
13.8
21
12
H26.4
ICD-10 Finland
After-cataract
1.7
13.8
274
1692
S18
ICPC
Laceration/cut
1.4
13.6
1182
9779
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
13.6
926
7373
SPAT1216
SPAT
Assessment of functional ability
1.5
13.5
425
2929
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
13.5
189
1054
PA2AD
NOMESCO Finland
CT angiography of brain
4.5
13.5
32
71
N29
ICPC
Neurological sympt/complt other
2.9
13.5
62
216
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
11.0
13.5
25
23
205
Kela drug reimbursment
Chronic hypertension
1.4
13.5
758
5844
XCW11
NOMESCO Finland
Assessment of strabismus
140.7
13.5
14
*
XCW20
NOMESCO Finland
Eye Movement Research, HESS
140.7
13.5
14
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.9
13.4
63
222
A28
ICPC
Limited function/disability NOS
1.5
13.4
481
3407
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
3.2
13.4
51
159
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
13.4
1061
8648
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
5.6
13.4
25
45
PAW37
NOMESCO Finland
Biopsy of temporal artery
4.9
13.3
29
60
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.7
13.3
42
116
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
13.3
198
1127
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
5.3
13.2
26
49
F95
ICPC
Strabismus
40.3
13.1
16
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.3
13.1
48
146
ZXA05
NOMESCO Finland
Left side
1.4
13.0
647
4877
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
16.8
13.0
20
12
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.8
13.0
62
221
K90
ICPC
Stroke/cerebrovascular accident
2.3
12.9
93
405
A10BB01
ATC
glibenclamide; oral
2.1
12.8
125
616
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
12.8
652
4932
H3600, E113,
ICD-10 Finland
3.3
12.7
46
139
H02AB06
ATC
prednisolone; systemic
1.3
12.7
1217
10185
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.5
12.6
75
299
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.0
12.6
35
88
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
12.6
417
2903
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
12.6
475
3396
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
12.6
893
7136
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.7
12.5
66
248
H50.59
ICD-10 Finland
Heterophor UNS
+∞
12.5
12
*
37303
ICD-8 Finland
Strabismus, Heterophoria (exophoria, esophroria, hypophoria)
+∞
12.5
12
*
3507
FHL
Retroposition and resection
+∞
12.5
12
*
H51.9
ICD-10 Finland
Disorder of binocular movement, unspecified
+∞
12.5
12
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
12.5
97
437
SPAT1260
SPAT
Consultation of another employee
1.5
12.5
445
3147
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
12.4
129
651
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
12.4
183
1038
UJF32
NOMESCO Finland
Coloscopy
1.4
12.4
671
5129
L28
ICPC
Limited function/disability (L)
1.5
12.3
475
3410
SPAT1310
SPAT
Counselling related to known health issue
1.4
12.3
790
6210
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
3.6
12.3
40
113
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
12.2
807
6372
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
12.1
849
6762
A10AD05
ATC
insulin aspart; parenteral
2.7
12.1
66
252
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.9
12.1
144
762
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
12.1
50
164
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
12.1
270
1717
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
12.0
336
2256
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
11.9
215
1293
A10AE06
ATC
insulin degludec; parenteral
2.3
11.9
93
420
101
Kela drug reimbursment
Anterior pituitary hypofunction
4.7
11.9
27
58
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
11.9
317
2105
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
11.8
558
4158
H16.0
ICD-10 Finland
Corneal ulcer
2.0
11.8
121
608
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
11.8
347
2354
CKC10
NOMESCO Finland
Local photocoagulation of retina
2.7
11.8
62
233
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.5
11.7
73
298
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
11.5
388
2710
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
5.7
11.5
21
37
3783A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia
+∞
11.5
11
*
C09AA05
ATC
ramipril; oral
1.4
11.4
674
5218
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.7
11.4
60
226
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
11.3
294
1940
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
11.3
1772
15798
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.3
585
4429
A06AD11
ATC
lactulose; oral
1.5
11.2
398
2810
S06.0
ICD-10 Finland
Concussion
1.6
11.2
264
1703
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
11.1
261
1680
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.5
11.1
37
106
L04AA31
ATC
[U] teriflunomide
12.7
11.1
19
15
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
9.2
11.0
22
24
N06AB10
ATC
escitalopram; oral
1.5
10.9
439
3173
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.9
10.9
139
754
G44.2
ICD-10 Finland
Tension-type headache
1.5
10.9
305
2047
N03AF02
ATC
oxcarbazepine; oral
2.2
10.8
87
398
L03AB08
ATC
interferon beta-1b; parenteral
11.9
10.8
19
16
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
10.8
337
2314
K91
ICPC
Cerebrovascular disease
3.0
10.7
46
155
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.7
10.7
33
90
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.8
10.5
51
184
D33.30
ICD-10 Finland
Acoustic neuroma
4.5
10.5
25
56
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
4.5
10.5
25
56
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
10.4
252
1634
37302
ICD-8 Finland
Strabismus, Concomitans sursum sive deorsum vergens
+∞
10.4
10
*
H52.5
ICD-10 Finland
Disorders of accommodation
+∞
10.4
10
*
3505
FHL
Single muscle resection
+∞
10.4
10
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
4.1
10.4
28
69
N06AX11
ATC
mirtazapine; oral
1.3
10.4
806
6495
N03AF01
ATC
carbamazepine; oral, rectal
1.9
10.4
132
716
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
16.1
10.3
16
10
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
10.3
175
1037
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
3.6
10.2
33
93
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.2
10.1
39
123
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
10.1
73
320
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
10.1
867
7084
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
3.5
10.0
33
94
H57.0
ICD-10 Finland
Anomalies of pupillary function
5.0
10.0
21
42
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
4.8
10.0
22
46
H3602, E113,
ICD-10 Finland
9.1
10.0
20
22
G04BD09
ATC
trospium; oral
2.4
10.0
68
290
NHQ40
NOMESCO Finland
Amputation of toe
2.8
10.0
49
178
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
9.9
845
6889
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
7.6
9.9
22
29
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
12.2
9.8
17
14
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
26.1
9.8
13
5
SPAT1325
SPAT
Vaccination
1.3
9.8
844
6891
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
4.4
9.8
24
55
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
9.7
235
1523
WX882
NOMESCO Finland
High dependency care
2.2
9.7
78
357
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
3.7
9.7
30
82
C09CA01
ATC
losartan; oral
1.4
9.7
650
5116
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
9.6
738
5925
A10BB12
ATC
glimepiride; oral
1.7
9.6
192
1188
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
4.5
9.5
23
52
S02.11
ICD-10 Finland
Fracture of base of skull, open
8.4
9.5
20
24
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
9.5
488
3678
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
7.1
9.5
22
31
H53.8
ICD-10 Finland
Other visual disturbances
3.0
9.4
40
134
S04.1
ICD-10 Finland
Injury of oculomotor nerve
100.4
9.4
10
*
H51.1
ICD-10 Finland
Convergence insufficiency and excess
100.4
9.4
10
*
G52.9
ICD-10 Finland
Cranial nerve disorder, unspecified
30.1
9.4
12
*
CBH25
NOMESCO Finland
Tarsorrhaphy
17.6
9.4
14
8
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
17.6
9.4
14
8
37301
ICD-8 Finland
Strabismus, Concomitans divergens
+∞
9.4
9
*
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.6
9.4
30
84
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.3
9.3
67
293
C03CA01
ATC
furosemide; systemic
1.3
9.3
820
6707
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.5
9.3
55
220
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.8
9.2
27
71
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
9.2
362
2601
TK800
NOMESCO Finland
Hemodialysis
2.5
9.2
58
239
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
9.2
225
1464
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
9.2
123
679
I63.8
ICD-10 Finland
Other cerebral infarction
3.3
9.2
33
100
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
9.2
353
2527
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
9.1
107
565
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
9.1
710
5704
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
9.1
273
1857
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
9.1
356
2555
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.4
9.0
31
91
B01AC07
ATC
dipyridamole; systemic
1.8
9.0
125
697
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
9.0
390
2852
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.6
9.0
50
194
A10BH01
ATC
sitagliptin; oral
1.5
9.0
248
1658
H25.0
ICD-10 Finland
Senile incipient cataract
1.7
8.9
164
993
C09AA02
ATC
enalapril; systemic
1.4
8.9
506
3875
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
8.8
587
4605
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
3.5
8.8
29
83
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
50.1
8.7
10
*
R11
ICD-10 Finland
Nausea and vomiting
1.6
8.7
199
1275
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
8.6
652
5213
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.6
8.6
20
44
R51
ICD-10 Finland
Headache
1.8
8.6
114
628
N07XX09
ATC
[U] dimethyl fumarate
11.6
8.6
15
13
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
11.6
8.6
15
13
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
11.6
8.6
15
13
N01
ICPC
Headache
1.6
8.5
217
1426
UKC02
NOMESCO Finland
Cystoscopy
1.4
8.5
416
3108
V03AE01
ATC
polystyrene sulfonate; oral
2.9
8.5
39
137
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.4
8.5
30
90
G91.8
ICD-10 Finland
Other hydrocephalus
20.1
8.5
12
6
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
8.4
308
2182
G04CA02
ATC
tamsulosin; oral
1.3
8.4
633
5056
D33.11
ICD-10 Finland
Brain stem
+∞
8.3
8
*
D33.12
ICD-10 Finland
Cerebellum
+∞
8.3
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.2
8.3
65
295
H25.8
ICD-10 Finland
Other senile cataract
1.5
8.3
289
2027
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
8.3
161
989
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
8.5
8.3
17
20
ZX120
NOMESCO Finland
Intravenous
1.5
8.3
227
1515
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
9.5
8.3
16
17
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
8.3
253
1730
-, ,
ICD-10 Finland
2.3
8.3
62
277
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
8.2
161
991
C10AX09
ATC
ezetimibe; oral
1.4
8.2
381
2820
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
14.5
8.2
13
9
ZXC86
NOMESCO Finland
Use of endoscopic device
4.5
8.1
19
42
XCW10
NOMESCO Finland
Assessment of vision
2.8
8.1
39
141
Z2446
NOMESCO Finland
Social worker
1.7
8.0
153
936
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
8.0
931
7867
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
8.0
643
5181
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
7.9
274
1919
J01FF01
ATC
clindamycin; systemic
1.3
7.9
642
5173
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.9
1063
9130
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
7.8
7.9
17
22
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
7.9
609
4877
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.6
7.8
25
70
G47.3
ICD-10 Finland
Sleep apnoea
1.3
7.8
522
4092
M79.6
ICD-10 Finland
Pain in limb
1.3
7.8
972
8272
SPAT1053
SPAT
Memory test
1.4
7.8
372
2765
N05CF01
ATC
zopiclone; oral
1.3
7.8
789
6548
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.8
961
8171
ZXA00
NOMESCO Finland
Right side
1.3
7.7
655
5308
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
7.7
593
4742
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
45.1
7.7
9
*
WX872
NOMESCO Finland
Intensive care
1.7
7.7
129
762
A46
ICD-10 Finland
Erysipelas
1.4
7.7
358
2649
WF099
NOMESCO Finland
Other radiotherapy
3.9
7.7
22
57
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
4.3
7.7
19
44
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
4.3
7.7
19
44
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
7.4
7.7
17
23
A10AA03, ,
ATC
3.2
7.7
29
91
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.7
7.7
128
756
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
7.7
591
4729
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
4.5
7.6
18
40
RS221, ,
NOMESCO Finland
2.7
7.6
40
151
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
7.6
429
3276
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.6
986
8427
D07AC01
ATC
betamethasone; topical
1.3
7.6
859
7224
C01DA14
ATC
isosorbide mononitrate; oral
1.4
7.5
417
3175
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
8.9
7.5
15
17
H05.2
ICD-10 Finland
Exophthalmic conditions
10.0
7.5
14
14
Z2445
NOMESCO Finland
Psychologist
2.0
7.5
82
424
SPAT1054
SPAT
Examination of peripheral nervous system
2.5
7.5
46
188
L04AA06
ATC
mycophenolic acid; systemic
2.5
7.5
45
182
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
7.5
267
1883
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
7.4
204
1363
183
Kela drug reimbursment
Lamotrigin and topiramate
3.9
7.4
21
54
78110
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Diplopia
80.3
7.4
8
*
A10BJ06
ATC
semaglutide; parenteral
1.8
7.4
112
643
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
7.4
393
2973
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
7.4
114
659
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
7.3
229
1572
K89
ICPC
Transient cerebral ischaemia
2.9
7.3
33
115
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.3
300
2171
A10AB06
ATC
insulin glulisine; parenteral
3.1
7.3
30
99
XCH00
NOMESCO Finland
Eye pressure measurement
1.8
7.3
113
653
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.8
7.3
96
528
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.7
7.3
135
820
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
7.3
89
478
CEC85
NOMESCO Finland
Combined correction of cyclodeviation
+∞
7.3
7
*
CEC50
NOMESCO Finland
Advancement of extraocular muscle
+∞
7.3
7
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
7.3
7
*
H50
ICD-10 Finland
Other strabismus
+∞
7.3
7
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
10.9
7.3
13
12
R13
ICD-10 Finland
Dysphagia
1.6
7.3
168
1079
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
9.4
7.3
14
15
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.3
166
1064
H40.0
ICD-10 Finland
Glaucoma suspect
1.6
7.3
182
1192
G50.1
ICD-10 Finland
Atypical facial pain
2.5
7.2
44
179
ZZC00
NOMESCO Finland
Graft of fascia
15.8
7.2
11
7
J01DA01
ATC
[U] cefalexin
1.2
7.2
1533
13810
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.9
7.2
33
116
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
7.2
153
964
R1250
NOMESCO Finland
Evaluation of functional capability
2.2
7.2
58
268
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
7.2
145
902
U02
ICPC
Urinary frequency/urgency
1.4
7.2
312
2283
G04BD12
ATC
mirabegron; oral
1.4
7.1
285
2053
H65.2
ICD-10 Finland
Chronic serous otitis media
2.8
7.1
35
128
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.1
308
2252
M86.6
ICD-10 Finland
Other chronic osteomyelitis
6.0
7.1
18
30
W19
ICD-10 Finland
Unspecified fall
1.5
7.1
232
1610
OAB50, ,
SPAT
1.7
7.0
128
774
G44.8
ICD-10 Finland
Other specified headache syndromes
2.7
7.0
36
135
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
7.0
7.0
16
23
N06AA09
ATC
amitriptyline; systemic
1.5
6.9
219
1507
SPAT1254
SPAT
Administration of medicine
1.4
6.9
358
2695
L01
ICPC
Neck symptom/complaint
1.4
6.9
331
2460
S97
ICPC
Chronic ulcer skin
1.6
6.9
152
965
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
5.5
6.9
19
35
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.9
6.9
31
108
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
4.0
6.9
19
48
H50.50
ICD-10 Finland
Alternating hyperphoria
13.8
6.9
11
8
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
6.9
109
635
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.8
402
3090
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
6.8
391
2993
N03AB02
ATC
phenytoin; systemic
2.8
6.8
33
120
R60.0
ICD-10 Finland
Localized oedema
1.4
6.8
287
2089
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.7
6.8
124
752
C07AB07
ATC
bisoprolol; oral
1.2
6.7
1257
11136
H53.3
ICD-10 Finland
Other disorders of binocular vision
5.7
6.7
18
32
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
6.7
325
2420
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.9
6.7
19
49
N02BF01
ATC
gabapentin; oral
1.5
6.7
182
1214
C08CA02
ATC
felodipine; oral
1.5
6.7
236
1661
G70.9
ICD-10 Finland
Myoneural disorder, unspecified
22.6
6.7
9
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.1
6.6
57
270
WX002
NOMESCO Finland
Sedation and analgesia
1.3
6.6
462
3638
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.8
6.6
32
116
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
3.7
6.6
20
54
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
6.4
6.6
16
25
Z50.1
ICD-10 Finland
Other physical therapy
1.7
6.6
124
757
J01CA04
ATC
amoxicillin; systemic
1.3
6.6
2053
19178
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.8
6.6
93
524
A02BC03
ATC
lansoprazole; oral
1.3
6.6
695
5778
XX4AW, ,
NOMESCO Finland
12.3
6.6
11
9
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.1
6.6
56
265
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
3.3
6.5
24
74
N02AA05
ATC
oxycodone; systemic
1.3
6.5
443
3474
N06AX16
ATC
venlafaxine; oral
1.4
6.5
282
2059
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
6.5
139
876
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.0
6.5
64
319
H3602, E103,
ICD-10 Finland
10.0
6.5
12
12
N04BB01
ATC
amantadine; oral
2.6
6.5
37
146
N30.0
ICD-10 Finland
Acute cystitis
1.4
6.5
352
2670
N17
ICPC
Vertigo/dizziness
1.4
6.5
282
2063
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.5
675
5602
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
6.4
110
655
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.6
6.4
145
927
L04AA40
ATC
cladribine; oral
70.0
6.4
7
*
N03AG01
ATC
valproic acid; systemic, rectal
1.6
6.4
129
802
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
2.7
6.4
33
124
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
7.4
6.4
14
19
M03BX01
ATC
baclofen; systemic
2.3
6.4
47
209
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
14.3
6.4
10
7
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
14.3
6.4
10
7
CBJ99
NOMESCO Finland
Other operation for ptosis
14.3
6.4
10
7
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
14.3
6.4
10
7
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
6.4
157
1025
G63.2
ICD-10 Finland
Diabetic polyneuropathy
4.1
6.4
17
42
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
6.3
149
963
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.3
6.3
43
185
H33.2
ICD-10 Finland
Serous retinal detachment
6.0
6.3
16
27
JDB10
NOMESCO Finland
Percutaneous gastrostomy
2.6
6.3
34
131
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
9.3
6.3
12
13
S22
ICPC
Nail symptom/complaint
1.6
6.3
143
917
H02AB02
ATC
dexamethasone; systemic
1.4
6.3
262
1903
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
18.1
6.3
9
5
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
6.3
94
540
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.3
6.2
46
205
AN4
HP
Balloon angioplasty and drug eluding stent
1.8
6.2
88
496
OAB43, ,
SPAT
0.7
6.2
282
3762
H02AB04
ATC
methylprednisolone; systemic
1.4
6.2
322
2426
CA1AD
NOMESCO Finland
Orbita CT
7.7
6.1
13
17
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.1
6.1
55
266
N03AX18
ATC
lacosamide; systemic
3.8
6.1
18
48
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
12.5
6.1
10
8
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
12.5
6.1
10
8
SPAT1234
SPAT
Support of social functional capacity
1.6
6.1
129
814
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
6.0
186
1276
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
6.0
1060
9306
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
174
124
14.88
192.39
1.1
1.1
3.38
5.95
nmol/l
0.55
34
27
256
544
5.07
114.05
1.5
1.4
564.82
552.50
mg/l
0.07
249
513
1250
7234
2.30
98.58
2.3
2.1
143.42
221.78
u/l
4.57
1194
6781
222
489
4.84
94.46
1.5
1.3
3.85
3.81
mmol/l
0.21
214
458
218
487
4.76
91.14
1.6
1.5
20.02
27.92
e6/l
0.22
172
372
218
487
4.76
91.14
1.6
1.6
781.94
859.43
e6/l
0.07
180
397
102
110
9.58
85.76
1.1
1.1
1.08
1.14
u/l
0.36
55
56
109
144
7.83
77.91
1.2
1.2
58.78
42.34
mg/l
0.48
81
119
106
137
8.00
77.18
1.1
1.1
—
—
—
0
0
104
138
7.78
74.04
1.1
1.1
361.93
288.99
mg/l
0.30
82
117
119
199
6.20
68.34
1.1
1.0
—
—
—
0
0
59
42
14.32
64.81
1.0
1.1
—
—
—
0
0
710
3755
2.19
64.59
1.9
2.1
28.92
29.97
s
5.32
678
3644
330
1347
2.64
53.18
1.3
1.3
80.87
57.10
au/ml
—
9
73
352
1487
2.56
52.86
2.4
2.4
12.28
24.95
au/ml
2.94
16
101
106
203
5.38
52.75
1.9
1.6
—
—
—
0
0
1814
13929
1.83
50.35
6.4
4.8
7.05
6.79
mmol/l
4.95
1722
13091
88
156
5.79
47.57
1.5
1.2
1.91
2.00
mmol/l
0.54
80
147
1290
9195
1.74
43.87
4.5
3.8
46.30
53.95
ng/l
0.32
993
6589
1521
11429
1.71
42.00
13.9
16.8
1.21
1.32
inr
5.04
411
3286
1420
10770
1.64
35.41
8.0
6.0
1.21
1.21
mmol/l
0.36
1303
9799
1524
11831
1.62
34.04
8.7
6.9
1.21
1.21
mmol/l
0.04
1291
10056
476
2814
1.83
28.93
8.1
7.2
1.17
1.13
mmol/l
0.07
379
2214
55
101
5.53
28.67
1.7
1.8
—
—
—
0
0
474
2820
1.82
28.15
8.2
7.2
12.35
12.15
kpa
0.35
449
2683
474
2820
1.82
28.15
8.2
7.2
5.10
5.10
kpa
0.02
447
2682
1849
15394
1.57
27.92
5.8
4.6
425.53
1503.67
e6/l
1.35
36
229
1333
10324
1.55
27.87
5.5
4.8
35.03
35.18
g/l
0.41
1254
9603
862
6067
1.60
27.26
5.0
4.2
0.00
0.00
estimate
1.28
267
2025
2002
17020
1.59
27.23
4.7
4.1
13.26
12.74
mm/h
0.77
1856
15695
319
1688
2.00
27.03
2.8
2.8
9.80
10.62
g/l
3.35
284
1534
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
57
122
4.75
25.01
1.2
1.1
—
—
—
0
0
422
2513
1.80
24.76
8.6
7.6
95.92
95.60
%
0.60
408
2409
55
116
4.82
24.56
1.3
1.1
—
—
—
0
0
46
83
5.62
24.45
1.1
1.1
1075.82
332.68
ng/l
—
10
19
203
945
2.24
23.99
1.8
1.8
36.13
38.75
u/l
1.00
180
824
1476
11926
1.49
23.78
7.3
6.0
0.20
0.19
e9/l
1.60
1309
10387
1413
11352
1.49
23.18
4.7
3.8
0.01
0.01
estimate
0.21
265
2047
1400
11233
1.48
23.08
4.6
3.8
0.00
0.00
estimate
0.99
286
2263
1392
11211
1.47
22.17
6.0
5.1
0.00
0.00
estimate
0.50
277
2118
1502
12287
1.47
22.03
6.6
6.2
10.81
11.80
umol/l
2.86
1430
11655
1113
8597
1.48
21.80
5.0
4.0
—
—
—
0
0
34
51
6.74
21.68
1.1
1.3
—
—
—
0
0
82
254
3.29
21.61
1.1
1.1
—
—
—
0
0
1454
11847
1.46
21.59
7.3
5.9
1.84
1.92
e9/l
0.84
1293
10413
384
2313
1.76
21.48
9.1
8.1
120.08
121.40
g/l
0.61
374
2242
2570
23713
1.86
21.30
23.8
17.6
139.56
139.63
mmol/l
0.63
2518
23098
2572
23778
1.85
20.60
23.9
17.8
3.98
3.98
mmol/l
0.14
2512
23127
2319
20859
1.60
20.59
5.3
4.7
1.95
2.09
mu/l
0.77
2117
18938
38
69
5.57
20.08
1.3
1.1
—
—
—
0
0
488
3190
1.64
20.06
7.2
6.0
1.06
1.04
mmol/l
0.94
457
2960
1975
17196
1.49
20.05
4.5
3.9
15.06
14.85
pmol/l
3.20
1781
15516
690
4900
1.54
19.88
5.3
4.2
1.02
1.02
kg/l
0.09
96
720
2492
22888
1.71
19.63
20.0
15.2
22.46
24.98
mg/l
3.76
2067
18295
35
60
5.89
19.63
1.0
1.1
—
—
—
0
0
1596
13393
1.44
19.30
10.0
9.0
4.41
4.19
e9/l
2.13
1419
11656
706
5097
1.51
18.66
3.2
2.6
4.42
5.29
e6/l
1.62
633
4589
339
2054
1.74
18.45
2.8
2.1
357.81
373.37
nmol/l
0.80
313
1867
34
61
5.63
18.20
1.0
1.1
—
—
—
0
0
576
4016
1.54
17.80
1.9
1.8
—
—
—
0
0
268
1532
1.83
17.75
10.2
7.0
24.91
24.49
mmol/l
1.14
254
1450
2032
17963
1.46
17.67
8.9
7.6
81.35
78.95
u/l
0.96
1912
16922
450
2970
1.61
17.61
9.3
7.3
—
—
—
0
0
40
87
4.65
17.27
1.1
1.2
—
—
—
0
0
797
5992
1.46
16.93
4.5
4.0
90.67
87.71
%
2.82
776
5838
52
143
3.69
16.50
1.7
1.7
—
—
—
0
0
34
68
5.05
16.20
1.1
1.1
—
—
—
0
0
917
7158
1.41
15.61
3.8
3.3
627.25
300.30
mg/l
0.97
628
4650
2309
21099
1.50
15.51
7.6
6.0
42.80
40.20
mmol/mol
19.50
2106
19421
31
60
5.21
15.32
1.1
1.1
—
—
—
0
0
33
68
4.90
15.20
1.1
1.1
—
—
—
0
0
324
2051
1.65
14.86
2.3
2.6
66.54
66.26
g/l
0.28
293
1885
921
7253
1.40
14.70
3.3
3.1
1458.94
1578.47
ng/l
0.35
791
6217
24
38
6.36
14.55
1.1
1.1
—
—
—
0
0
348
2261
1.61
14.37
8.5
7.3
9.82
10.23
mmol/l
0.52
330
2147
1317
11024
1.36
14.31
3.0
2.6
—
—
—
0
0
1264
10535
1.36
14.01
7.5
6.0
0.65
0.66
%
0.30
1183
9813
627
4645
1.45
13.98
1.8
1.8
1200.18
1168.80
nmol/l
0.36
488
3502
853
6676
1.40
13.97
3.7
3.2
0.34
0.45
e6/l
1.31
693
5132
921
7306
1.39
13.90
3.0
2.5
55.86
70.51
u/l
0.71
846
6745
112
513
2.23
13.82
1.7
1.8
3.70
4.68
iu/l
0.50
42
172
945
7541
1.38
13.71
4.5
3.9
13.90
9.01
mg/mmol
1.72
634
4830
410
2802
1.54
13.57
1.8
1.7
—
—
—
0
0
1291
10846
1.35
13.36
7.6
6.0
2.91
2.83
%
0.52
1205
10119
406
2792
1.53
13.03
1.8
1.8
—
—
—
0
0
1294
10905
1.34
12.99
7.8
6.4
8.83
8.73
%
0.55
1212
10189
934
7501
1.36
12.82
3.7
3.2
7.37
7.50
mmol/l
0.40
768
6318
69
263
2.66
12.72
1.4
1.6
—
—
—
0
0
330
2204
1.56
12.05
2.6
2.4
7.43
7.20
ug/l
0.04
283
1939
25
29
8.69
11.99
1.1
1.2
—
—
—
0
0
117
583
2.05
11.68
1.8
1.9
10.91
11.49
mg/l
0.30
109
529
215
1302
1.70
11.63
9.1
9.2
24.34
24.33
mmol/l
0.01
207
1262
1020
8399
1.33
11.58
4.4
3.8
155.83
106.91
e6/l
0.39
773
6047
28
64
4.41
11.44
1.1
1.1
—
—
—
0
0
1308
11186
1.31
11.26
7.7
6.1
26.51
27.23
%
1.48
1227
10479
24
30
8.06
11.06
1.1
1.2
—
—
—
0
0
1287
11003
1.31
11.02
7.4
5.9
58.27
57.69
%
0.94
1203
10298
118
604
1.99
10.96
1.5
1.5
0.24
0.24
g/l
0.10
113
573
768
6110
1.35
10.84
2.4
2.2
3.17
3.00
mg/l
1.11
680
5165
521
3891
1.41
10.82
3.5
3.3
0.82
0.82
mmol/l
0.83
488
3652
121
629
1.96
10.76
1.5
1.5
1.21
1.18
g/l
0.77
116
596
1116
9384
1.31
10.69
2.5
2.2
76.65
77.79
nmol/l
0.65
1002
8335
62
245
2.56
10.69
1.4
1.6
—
—
—
0
0
2557
24255
1.53
10.61
13.3
10.6
26.08
26.05
u/l
0.03
2456
23351
40
125
3.23
10.54
1.1
1.2
—
—
—
0
0
175
1031
1.74
10.46
1.9
1.9
3.78
2.25
ug/l
0.46
147
905
319
2180
1.52
10.46
7.6
6.8
1.34
1.41
mmol/l
0.64
311
2133
1160
9846
1.30
10.23
2.1
2.0
94.88
93.83
pmol/l
0.31
586
5159
732
5839
1.34
10.02
2.7
2.4
—
—
—
0
0
445
3275
1.43
9.98
3.2
2.6
22.13
22.97
%
0.53
373
2803
887
7279
1.32
9.96
4.0
3.3
67.83
75.88
e6/l
0.19
716
5643
198
1226
1.66
9.87
4.3
3.3
25.20
25.19
mmol/l
0.01
192
1184
500
3763
1.40
9.86
3.1
2.5
12.27
12.92
umol/l
1.19
464
3505
651
5134
1.35
9.56
1.7
1.7
19288839.12
30406623.98
pmol/l
0.23
534
4259
18
19
9.53
9.26
1.0
1.1
—
—
—
0
0
463
3474
1.40
9.25
3.1
2.5
2.23
2.29
g/l
1.51
428
3209
224
1463
1.58
8.99
1.6
1.5
—
—
—
0
0
330
2353
1.46
8.74
5.0
3.7
2.11
1.97
mmol/l
0.31
282
1947
1179
10168
1.27
8.73
11.7
9.8
0.00
0.00
e9/l
1.88
994
8267
2354
22149
1.36
8.72
5.2
4.7
6.25
6.00
mmol/l
9.61
2132
20010
264
1812
1.50
8.46
4.5
3.9
108.96
92.53
ng/l
0.83
234
1564
42
155
2.74
8.35
2.9
2.3
462.54
554.26
e6/l
0.56
37
129
117
656
1.82
8.33
1.7
1.6
0.21
10.44
iu/ml
0.57
30
131
133
775
1.75
8.31
1.6
1.5
431.43
238.71
titre
—
7
31
636
5089
1.32
8.31
1.8
1.7
1.34
1.31
mg/l
0.07
490
3919
17
20
8.54
8.29
1.1
1.2
—
—
—
0
0
528
4114
1.35
8.27
3.2
2.8
1.26
1.20
e6/l
0.14
336
2360
1621
14578
1.26
8.22
3.7
3.1
57.79
51.60
u/l
1.13
1492
13510
327
2359
1.44
8.12
4.8
3.7
5.86
5.84
kpa
0.12
314
2282
1116
9624
1.26
8.08
3.2
2.8
163.85
137.23
ug/l
1.46
1029
8838
17
21
8.14
8.08
2.6
2.3
—
—
—
0
0
134
790
1.73
8.05
1.2
1.2
1.03
1.07
u/ml
0.02
17
70
109
608
1.82
7.90
2.6
2.2
133.19
107.25
ug/min
0.31
64
377
946
8015
1.27
7.90
3.2
3.4
2.35
2.35
mmol/l
0.07
813
7014
2625
25268
1.50
7.67
29.9
22.3
39.79
40.11
%
0.75
2438
23555
106
595
1.81
7.55
2.4
1.6
382.77
305.34
mu/l
0.86
98
542
28
87
3.24
7.52
1.1
1.1
1508.18
1574.94
miu/ml
0.09
28
87
2625
25281
1.49
7.51
29.7
22.2
248.60
247.02
e9/l
0.60
2570
24598
274
1942
1.45
7.48
4.1
3.1
4.54
4.59
kpa
0.12
259
1874
138
838
1.68
7.46
2.0
2.2
262.57
499.07
ug/l
1.83
133
791
2625
25294
1.49
7.34
29.7
22.2
7.00
6.77
e9/l
3.45
2561
24512
2625
25295
1.49
7.33
29.7
22.2
4.46
4.47
e12/l
0.22
2563
24513
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
141
867
1.66
7.28
2.5
2.9
0.34
0.34
u/ml
0.05
71
494
2625
25303
1.48
7.23
29.9
22.3
133.81
134.84
g/l
2.82
2591
24905
18
29
6.24
7.23
1.2
1.2
—
—
—
0
0
2274
21453
1.30
7.05
4.6
4.0
1.34
1.30
mmol/l
1.77
2060
19467
200
1352
1.52
6.91
1.8
1.9
1.10
1.39
g/l
2.55
188
1233
15
20
7.53
6.89
1.0
1.0
—
—
—
0
0
2354
22346
1.31
6.71
5.1
4.5
4.42
4.58
mmol/l
11.13
2160
20591
2338
22176
1.30
6.69
5.1
4.5
1.42
1.44
mmol/l
1.83
2137
20294
2399
22842
1.32
6.62
5.7
5.0
2.54
2.69
mmol/l
12.10
2201
20911
154
994
1.58
6.56
6.6
5.3
1.70
1.63
%
0.29
143
924
100
577
1.76
6.54
1.6
1.6
—
—
—
0
0
195
1328
1.50
6.52
10.2
9.9
—
—
—
0
0
128
792
1.65
6.48
2.6
3.5
37.90
70.39
mg/l
1.08
105
647
44
189
2.35
6.48
2.4
2.3
648.24
633.20
ml
0.10
29
122
22
65
3.40
6.41
3.9
2.1
—
—
—
0
0
369
2826
1.35
6.40
4.6
4.1
239.44
243.66
u/l
0.27
351
2669
80
435
1.86
6.36
1.6
1.6
—
—
—
0
0
217
1519
1.46
6.33
4.5
3.2
127.62
128.64
g/l
0.27
212
1473
114
689
1.68
6.32
1.8
1.7
—
—
—
0
0
516
4153
1.30
6.30
1.6
1.5
2.67
2.53
g/l
0.38
333
2513
16
27
5.95
6.29
1.1
1.0
—
—
—
0
0
15
24
6.28
6.15
1.2
1.2
—
—
—
0
0
260
1893
1.41
6.14
2.6
2.6
63.20
64.82
ml/min/173m2
0.31
126
777
13
17
7.68
6.12
1.1
1.1
—
—
—
0
0
571
4676
1.28
6.07
1.3
1.2
1.12
1.56
u/ml
0.57
158
1202
123
768
1.63
6.03
2.6
3.5
1.47
1.81
ratio
0.49
12
64
126
793
1.62
5.99
2.6
3.5
61.29
56.30
mg/l
0.16
102
646
285
2125
1.38
5.85
2.5
2.6
65.73
70.22
e9/l
1.61
232
1622
149
987
1.54
5.70
6.6
5.4
0.92
0.89
%
0.32
139
919
100
606
1.67
5.54
1.7
1.6
—
—
—
0
0
44
203
2.19
5.53
1.1
1.1
—
—
—
0
0
15
28
5.38
5.53
1.3
1.1
48.44
47.10
%
—
9
10
366
2860
1.32
5.52
3.1
2.5
1.75
1.80
%
0.51
325
2518
70
384
1.84
5.46
1.8
1.9
4.50
5.02
mmol/24h
0.60
61
328
263
1958
1.38
5.46
5.1
3.9
1.23
1.22
mmol/l
0.16
235
1694
211
1513
1.43
5.45
3.6
3.7
1.83
1.83
mmol/l
0.00
157
1112
116
734
1.61
5.42
1.4
1.3
—
—
—
0
0
98
596
1.67
5.36
1.5
1.6
—
—
—
0
0
673
5690
1.24
5.36
1.6
1.6
21.11
20.15
nmol/l
0.47
581
4830
113
1733
0.64
5.24
1.6
1.8
—
—
—
0
0
219
1597
1.40
5.15
3.6
3.8
5.14
5.15
kpa
0.05
209
1520
21
70
3.01
5.10
3.5
2.2
1.48
1.27
ug/l
0.12
21
64
73
417
1.77
5.02
1.3
1.5
—
—
—
0
0
83
494
1.70
4.95
2.9
1.7
0.69
0.85
nmol/l
1.90
65
402
103
650
1.61
4.90
1.9
1.6
—
—
—
0
0
179
1272
1.43
4.88
3.3
3.2
4.42
4.47
pmol/l
0.30
162
1108
87
529
1.66
4.80
2.7
2.9
33.70
36.96
umol/l
0.39
79
476
137
932
1.49
4.68
1.7
1.8
—
—
—
0
0
88
545
1.63
4.54
1.1
1.1
—
—
—
0
0
2253
21531
1.22
4.49
17.7
14.2
78.32
78.80
ml/min/173m2
0.44
1937
17806
323
2553
1.30
4.49
4.1
3.5
—
—
—
0
0
841
7383
1.20
4.48
3.5
3.2
34.74
36.60
u/l
0.26
793
7009
64
366
1.77
4.43
1.3
1.4
—
—
—
0
0
162
1155
1.43
4.37
1.6
1.8
1.62
1.52
g/l
0.63
138
992
234
1775
1.35
4.35
1.8
1.6
—
—
—
0
0
35
164
2.15
4.31
2.1
2.4
—
—
—
0
0
141
983
1.46
4.29
3.7
4.1
25.07
24.78
mmol/l
0.67
130
916
8
9
8.91
4.28
1.3
1.0
—
—
—
0
0
45
233
1.95
4.25
3.7
2.6
—
—
—
0
0
28
121
2.33
4.17
1.1
1.2
1.07
1.04
ratio
—
6
47
42
214
1.98
4.16
1.1
1.2
—
—
—
0
0
76
465
1.65
4.14
6.6
5.4
394.38
681.13
iu/ml
0.40
13
69
201
1504
1.36
4.09
1.7
1.6
—
—
—
0
0
121
830
1.48
4.02
2.8
2.6
—
—
—
0
0
330
2656
1.27
3.99
3.0
2.8
6.90
8.50
umol/l
1.18
285
2337
57
326
1.76
3.98
4.4
5.2
343.61
351.84
umol/l
0.16
46
287
85
541
1.59
3.97
2.1
1.4
8.92
9.40
u/l
0.13
69
432
24
99
2.44
3.97
1.9
2.4
554.25
1332.91
u/ml
1.96
24
99
28
124
2.27
3.96
1.3
1.5
5.40
8.23
u/l
1.14
20
107
554
4725
1.21
3.95
4.2
3.8
399.15
641.77
ng/l
0.43
456
3838
363
2964
1.26
3.89
4.8
4.5
32.89
32.61
%
0.18
273
1995
525
4484
1.21
3.68
2.9
3.0
2.45
2.45
mmol/l
0.38
454
3930
41
217
1.90
3.68
1.5
1.6
—
—
—
0
0
41
217
1.90
3.68
1.5
1.6
—
—
—
0
0
41
217
1.90
3.68
1.5
1.6
—
—
—
0
0
66
405
1.64
3.60
1.4
1.6
—
—
—
0
0
66
405
1.64
3.60
1.4
1.6
—
—
—
0
0
966
8721
1.16
3.51
5.2
5.1
4.30
3.53
ug/l
0.18
854
7794
46
258
1.80
3.47
1.6
1.8
—
1226.67
—
0
9
74
473
1.58
3.44
2.9
3.5
59.09
58.06
%
0.30
74
473
11
27
4.09
3.39
1.5
1.9
—
—
—
0
0
685
6035
1.18
3.37
1.8
1.6
1.37
1.37
mmol/l
0.02
569
5030
93
629
1.49
3.36
4.3
4.0
1.59
1.59
mg/l
0.02
83
568
54
322
1.69
3.31
1.3
1.5
—
—
—
0
0
71
456
1.57
3.26
2.8
3.3
4.10
4.27
e9/l
0.30
71
456
64
402
1.61
3.22
1.2
1.2
38.63
48.91
u/ml
—
9
38
131
954
1.39
3.21
1.9
2.4
3.92
3.65
g/l
0.57
117
869
703
6231
1.17
3.20
3.2
2.8
2710.64
5674.71
umol/l
1.45
626
5415
131
955
1.39
3.19
1.9
2.4
7.62
7.38
g/l
0.85
117
869
131
955
1.39
3.19
1.9
2.4
—
—
—
0
0
124
896
1.40
3.18
2.0
2.4
9.70
10.20
g/l
0.83
110
805
67
427
1.58
3.18
1.3
1.2
56.23
41.77
u/l
0.17
58
368
21
91
2.32
3.17
1.3
2.7
73.00
110.77
umol/l
0.87
12
56
1428
13339
1.14
3.09
2.9
2.8
—
—
—
0
0
44
254
1.74
3.05
1.3
1.3
17.99
25.49
u/l
1.43
38
203
21
93
2.27
3.03
1.1
1.0
—
—
—
0
0
47
278
1.70
3.00
1.2
1.5
—
—
—
0
0
47
278
1.70
3.00
1.2
1.5
—
—
—
0
0
11
31
3.56
2.99
3.7
1.3
—
—
—
0
0
430
3679
1.20
2.95
1.2
1.3
32.51
36.24
iu/ml
0.18
110
1161
55
342
1.62
2.91
1.5
1.6
—
—
—
0
0
81
551
1.48
2.89
10.0
7.3
105.90
105.16
mmol/l
0.65
71
487
280
2300
1.24
2.88
2.3
2.2
0.21
0.21
g/l
0.06
254
2143
48
289
1.67
2.88
15.6
5.9
8.44
7.33
mmol/l
1.30
43
246
72
479
1.52
2.86
1.4
1.7
—
—
—
0
0
79
538
1.48
2.82
1.2
1.2
2.94
8.63
u/ml
1.24
16
85
78
530
1.48
2.81
1.2
1.2
1.30
3.81
u/ml
2.11
12
51
79
540
1.48
2.77
3.0
2.6
17.29
16.02
%
1.51
41
273
81
558
1.46
2.74
2.1
2.2
129.40
128.78
g/l
0.07
60
405
11
34
3.24
2.72
7.6
12.7
5.11
5.93
mmol/l
0.72
11
34
17
72
2.37
2.72
2.1
2.3
—
—
—
0
0
19
87
2.19
2.57
1.4
1.2
—
—
—
0
0
28
149
1.89
2.56
1.3
1.2
—
—
—
0
0
74
509
1.47
2.54
2.1
2.2
4151.00
3593.57
u/l
0.07
25
211
21
101
2.09
2.52
1.8
1.7
—
—
—
0
0
28
150
1.88
2.51
1.3
1.2
—
—
—
0
0
25
129
1.95
2.50
1.0
1.0
—
—
—
0
0
56
365
1.54
2.48
1.3
1.2
—
—
—
0
0
12
45
2.67
2.45
1.0
1.1
—
5.80
pmol/l
—
0
8
78
547
1.44
2.44
1.2
1.3
—
—
—
0
0
21
103
2.05
2.41
1.2
1.2
—
—
—
0
0
42
258
1.64
2.39
1.4
1.4
276.82
277.81
mosm/kgh2o
0.10
34
188
118
892
1.34
2.37
2.0
2.4
2.87
2.98
g/l
0.47
104
807
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
63
429
1.48
2.30
1.2
1.2
1.19
5.16
u/ml
—
7
29
27
148
1.83
2.28
2.7
2.7
41.05
40.58
%
0.05
20
83
48
309
1.56
2.27
2.5
2.3
32.64
23.90
mg/l
0.33
11
74
20
99
2.03
2.26
1.8
1.7
—
—
—
0
0
20
99
2.03
2.26
1.8
1.7
—
—
—
0
0
24
127
1.90
2.26
2.5
2.4
—
—
—
0
0
764
6966
1.13
2.25
4.5
4.4
22.69
21.67
%
0.97
375
3496
132
1024
1.30
2.23
2.0
1.9
—
—
—
0
0
380
3310
1.17
2.14
1.5
1.5
—
—
—
0
0
33
197
1.68
2.12
1.7
1.6
—
—
—
0
0
18
345
0.52
2.11
1.4
1.5
—
—
—
0
0
22
116
1.90
2.10
1.2
1.4
—
—
—
0
0
7
20
3.51
2.05
1.0
1.1
—
—
—
0
0
107
817
1.32
2.05
2.1
2.5
1.57
1.17
g/l
0.29
90
713
99
750
1.33
2.01
1.9
1.4
25.42
29.04
iu/l
0.47
83
634
43
281
1.54
1.95
1.3
1.3
—
—
—
0
0
401
3536
1.16
1.94
1.2
1.2
14.19
12.86
u/ml
0.10
147
1342
10
39
2.57
1.94
1.1
2.1
—
—
—
0
0
8
27
2.97
1.93
1.0
1.1
—
—
—
0
0
163
1325
1.24
1.93
1.3
1.2
170.01
155.79
iu/ml
0.16
66
476
15
71
2.12
1.92
1.5
1.2
—
—
—
0
0
49
331
1.49
1.91
1.4
1.5
—
—
—
0
0
434
3853
1.15
1.91
3.5
3.0
3.15
2.22
e6/l
0.89
241
2113
98
752
1.31
1.84
2.1
2.3
37.14
37.63
g/l
0.37
84
667
28
167
1.68
1.84
1.0
1.0
29.94
46.76
ng/l
1.62
14
101
28
167
1.68
1.84
1.0
1.0
735.93
670.03
ng/l
0.24
15
100
2018
19549
1.11
1.80
23.0
17.9
15.21
15.06
%
0.55
1987
19174
8
29
2.76
1.79
1.0
1.0
—
—
—
0
0
31
192
1.62
1.77
1.0
1.0
—
—
—
0
0
73
541
1.36
1.74
1.5
1.4
—
—
—
0
0
88
680
1.30
1.61
2.1
2.4
0.00
0.00
g/l
-0.00
80
628
92
716
1.29
1.60
2.1
2.4
0.00
0.02
g/l
1.79
84
662
27
167
1.62
1.58
1.0
1.0
196.21
320.72
ng/l
2.40
14
104
27
167
1.62
1.58
1.1
1.2
—
—
—
0
0
87
674
1.30
1.57
2.2
2.4
0.00
0.00
g/l
-0.00
80
627
21
122
1.73
1.54
5.8
3.4
—
—
—
0
0
22
131
1.68
1.49
1.2
1.4
1.04
1.13
nmol/l
0.15
14
96
146
1211
1.22
1.49
5.9
3.9
24.04
24.09
mmol/l
0.07
139
1183
40
276
1.46
1.47
1.2
1.1
—
—
—
0
0
40
277
1.45
1.44
1.6
1.6
—
—
—
0
0
203
1745
1.18
1.41
2.5
2.2
11.71
12.60
nmol/l
0.73
177
1546
54
398
1.36
1.39
1.8
1.4
107.04
122.78
u/ml
0.56
15
76
68
520
1.32
1.38
1.2
1.3
—
—
—
0
0
68
520
1.32
1.38
1.2
1.3
—
—
—
0
0
12
60
2.00
1.38
1.1
1.2
—
—
—
0
0
10
47
2.13
1.33
1.3
1.3
—
—
—
0
0
20
321
0.62
1.33
1.4
1.4
—
—
—
0
0
20
321
0.62
1.33
1.4
1.4
—
—
—
0
0
20
321
0.62
1.33
1.4
1.4
—
—
—
0
0
20
320
0.62
1.32
1.4
1.4
—
—
—
0
0
5
18
2.78
1.28
1.0
1.3
—
—
—
0
0
8
35
2.29
1.26
2.3
2.1
—
—
—
0
0
22
138
1.60
1.26
1.3
1.5
10.75
6.36
u/l
0.54
16
113
85
679
1.26
1.26
1.4
1.4
270.74
278.99
ug/g
0.15
54
396
286
2547
1.14
1.26
2.3
2.2
161.35
145.94
ug/g
0.24
215
2021
46
339
1.36
1.21
1.1
1.2
6.69
3.13
u/ml
0.32
16
112
8
37
2.17
1.21
2.3
2.1
—
—
—
0
0
10
50
2.00
1.16
1.0
1.1
—
—
—
0
0
12
65
1.85
1.13
1.6
1.2
—
—
—
0
0
45
597
0.75
1.13
1.4
1.5
—
—
—
0
0
25
168
1.49
1.09
1.2
1.1
—
4.38
—
0
8
12
66
1.82
1.09
1.1
1.1
—
—
—
0
0
81
658
1.24
1.07
1.3
1.1
—
—
—
0
0
55
426
1.30
1.07
1.3
1.3
—
—
—
0
0
20
129
1.55
1.05
1.9
1.7
—
—
—
0
0
20
129
1.55
1.05
1.9
1.7
—
—
—
0
0
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
5
22
2.27
1.03
12.2
5.0
—
—
—
0
0
12
203
0.59
1.03
1.3
1.5
—
—
—
0
0
26
179
1.46
1.03
1.2
1.1
—
50.13
—
0
8
7
34
2.06
1.03
7.7
5.1
—
—
—
0
0
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
19
122
1.56
1.02
2.7
3.5
—
—
—
0
0
81
664
1.23
1.00
1.3
1.1
—
—
—
0
0
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
9
49
1.84
0.98
1.2
1.3
—
—
—
0
0
9
159
0.56
0.98
2.3
1.5
120.00
88.09
umol/l
—
9
159
34
249
1.37
0.97
1.7
1.5
0.21
0.31
nmol/l
1.17
28
190
15
92
1.63
0.97
1.1
1.3
—
—
—
0
0
9
51
1.77
0.94
1.0
1.2
—
—
—
0
0
43
329
1.31
0.94
1.0
1.2
4.54
4.68
u/ml
0.02
13
148
11
62
1.78
0.94
1.5
1.6
63.91
183.52
nmol/24h
0.61
11
62
12
70
1.72
0.92
1.2
1.2
108.58
110.66
%
0.12
12
62
14
87
1.61
0.87
1.2
1.3
154.50
168.88
mmol/24h
0.25
14
87
241
2189
1.11
0.82
2.8
2.4
42.84
59.90
u/l
0.33
197
1862
81
683
1.19
0.80
1.7
1.7
—
—
—
0
0
39
303
1.29
0.79
1.1
1.4
—
—
—
0
0
5
25
2.00
0.72
1.0
1.5
—
—
—
0
0
5
25
2.00
0.72
1.2
1.4
—
—
—
0
0
7
39
1.80
0.72
1.3
3.5
50.29
42.25
umol/l
—
7
31
34
264
1.29
0.71
1.4
1.3
332.79
312.30
pmol/l
0.12
29
226
38
301
1.27
0.69
1.1
1.4
—
—
—
0
0
83
714
1.17
0.68
2.0
1.7
—
—
—
0
0
19
136
1.40
0.66
1.5
1.6
—
—
—
0
0
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
26
197
1.32
0.65
1.2
1.2
—
—
—
0
0
23
172
1.34
0.63
1.6
1.2
—
—
—
0
0
20
268
0.74
0.62
1.6
1.7
—
—
—
0
0
47
388
1.21
0.61
1.1
1.1
2643.68
86.30
iu/ml
0.50
13
84
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
44
361
1.22
0.61
1.1
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
23
174
1.32
0.60
1.3
1.5
13.65
13.66
u/l
0.00
23
167
35
281
1.25
0.59
1.4
1.6
58.00
62.78
%
0.26
18
175
16
114
1.41
0.58
1.2
1.2
143.81
139.18
nmol/l
0.07
16
114
10
64
1.56
0.58
1.0
1.5
—
—
—
0
0
7
115
0.61
0.57
1.1
1.3
—
—
—
0
0
6
35
1.72
0.57
1.0
1.1
106.83
95.60
%
—
6
35
39
319
1.23
0.57
1.0
1.1
—
—
—
0
0
22
168
1.31
0.55
1.1
1.4
1.41
1.24
promille
0.16
13
129
24
186
1.29
0.54
1.7
1.5
39.83
23.17
u/ml
—
6
36
13
91
1.43
0.53
1.5
2.6
253.29
718.00
e6/l
—
7
76
36
295
1.22
0.53
1.1
1.4
—
—
—
0
0
24
188
1.28
0.51
1.4
1.6
—
—
—
0
0
95
848
1.12
0.50
1.0
1.1
—
1.55
—
0
11
74
650
1.14
0.50
1.6
1.7
—
—
—
0
0
68
594
1.15
0.50
1.5
1.3
—
—
—
0
0
29
357
0.81
0.50
1.1
1.1
0.16
2.21
u/ml
4.43
13
198
18
136
1.33
0.49
1.6
2.2
209.20
137.18
ug/min
—
5
34
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
15
110
1.37
0.48
2.7
6.8
—
58.44
—
0
32
47
401
1.17
0.47
1.4
1.3
225.74
268.68
u/ml
0.67
35
242
18
137
1.32
0.47
1.6
1.6
—
—
—
0
0
22
277
0.79
0.46
1.0
1.0
2.04
2.44
u/ml
—
10
114
116
1056
1.10
0.45
1.1
1.1
—
—
—
0
0
115
1047
1.10
0.45
1.3
1.3
—
—
—
0
0
23
183
1.26
0.44
1.3
1.2
—
314.00
—
0
5
67
757
0.88
0.44
1.6
1.6
2.90
4.08
mg/l
0.58
50
555
522
5022
1.05
0.43
2.9
3.1
0.74
0.76
ug/l
0.12
362
3420
5
32
1.56
0.42
1.2
1.3
—
—
—
0
0
19
149
1.28
0.41
1.4
1.2
—
—
—
0
0
35
295
1.19
0.41
1.1
1.4
—
—
—
0
0
24
294
0.81
0.41
1.4
1.5
—
—
—
0
0
11
79
1.39
0.40
1.2
1.6
—
1958833.33
—
0
6
26
214
1.22
0.39
1.2
1.5
31.78
28.16
%
0.16
13
132
35
297
1.18
0.39
1.1
1.4
—
—
—
0
0
20
160
1.25
0.38
1.5
1.5
—
—
—
0
0
11
80
1.38
0.38
1.5
1.4
—
—
—
0
0
35
298
1.18
0.38
1.1
1.4
—
—
—
0
0
58
517
1.12
0.35
1.2
1.4
—
—
—
0
0
15
117
1.28
0.35
1.1
1.2
—
—
—
0
0
34
394
0.86
0.34
1.5
1.5
—
—
—
0
0
18
145
1.24
0.33
2.6
1.7
—
—
—
0
0
40
350
1.14
0.32
1.4
1.6
—
—
—
0
0
10
74
1.35
0.32
2.2
2.5
—
—
—
0
0
10
74
1.35
0.32
2.2
2.5
—
—
—
0
0
50
447
1.12
0.30
1.3
1.5
79.69
216.13
pmol/l
2.70
50
441
7
57
1.23
0.29
1.7
1.6
—
—
—
0
0
8
110
0.73
0.28
1.1
1.4
—
—
—
0
0
8
110
0.73
0.28
1.1
1.4
—
—
—
0
0
8
64
1.25
0.27
2.0
1.4
9.56
8.91
ug/l
—
8
64
63
576
1.10
0.27
1.1
1.1
1.40
5.85
u/ml
—
5
62
59
539
1.10
0.26
3.3
3.1
0.74
0.82
nmol/l
1.22
43
416
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
15
124
1.21
0.24
2.7
1.6
—
—
—
0
0
15
124
1.21
0.24
2.7
1.6
—
—
—
0
0
263
2539
1.04
0.23
3.5
4.1
6.04
21.09
ug/l
2.93
222
2098
134
1275
1.05
0.22
1.4
1.3
142.20
203.72
u/ml
1.14
124
1175
22
191
1.15
0.22
5.2
4.8
264.56
55.31
u/ml
—
8
57
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
2.45
—
0
11
0
10
0.00
0.21
0.0
1.8
—
1.49
—
0
10
19
219
0.87
0.20
1.4
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
0.01
—
0
9
9
115
0.78
0.20
1.0
1.1
—
—
—
0
0
6
50
1.20
0.19
2.0
1.3
—
—
—
0
0
65
607
1.07
0.19
1.3
1.2
—
—
—
0
0
59
549
1.08
0.19
1.5
1.4
—
—
—
0
0
256
2482
1.03
0.19
1.6
1.8
1.51
1.51
%
0.03
210
2168
13
154
0.84
0.19
1.1
1.1
—
—
—
0
0
13
154
0.84
0.19
1.1
1.1
—
—
—
0
0
13
154
0.84
0.19
1.1
1.1
—
—
—
0
0
173
1797
0.96
0.19
1.9
2.0
—
—
—
0
0
96
910
1.06
0.19
2.1
1.8
—
—
—
0
0
226
2190
1.03
0.18
3.3
2.9
262.22
215.07
ng/l
0.54
205
1988
58
542
1.07
0.17
6.8
3.6
26.69
27.82
mg/l
0.09
33
336
11
130
0.85
0.16
1.0
1.1
—
—
—
0
0
13
151
0.86
0.15
1.1
1.1
—
—
—
0
0
13
151
0.86
0.15
1.1
1.1
—
—
—
0
0
36
333
1.08
0.14
1.1
1.1
—
—
—
0
0
56
593
0.94
0.14
1.6
1.7
5024.58
15557.00
e6/l
3.70
40
421
25
228
1.10
0.13
1.8
2.3
—
—
—
0
0
24
262
0.92
0.12
3.5
3.7
—
—
—
0
0
25
229
1.09
0.12
1.4
1.3
192842.88
94720.96
e6/l
0.22
17
157
62
651
0.95
0.12
1.4
1.4
—
—
—
0
0
93
895
1.04
0.12
2.8
3.3
93.02
4747.65
u/ml
0.88
80
766
10
116
0.86
0.12
2.0
1.5
15.90
6.94
ug/l
—
10
101
21
191
1.10
0.11
2.4
2.0
24.21
10.98
umol/l
0.29
14
131
27
292
0.92
0.11
1.1
1.1
0.06
1.71
u/ml
3.86
12
152
64
611
1.05
0.11
1.4
1.4
—
—
—
0
0
299
2936
1.02
0.11
1.4
1.4
—
—
—
0
0
18
198
0.91
0.10
1.1
1.0
0.18
0.41
u/ml
—
5
62
100
1032
0.97
0.10
3.2
3.5
34.20
64.08
u/ml
1.52
93
996
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
30
319
0.94
0.09
1.4
1.4
20441.96
1771.60
e6/l
0.50
25
234
17
155
1.10
0.09
1.3
1.4
164.52
212.02
pmol/l
0.34
17
155
166
1625
1.02
0.09
1.8
1.9
—
—
—
0
0
22
237
0.93
0.09
1.0
1.1
0.87
2.74
u/ml
1.62
13
112
6
74
0.81
0.07
1.2
1.1
—
—
—
0
0
14
153
0.91
0.07
1.2
1.4
—
—
—
0
0
55
532
1.03
0.06
1.2
1.3
196.53
221.33
miu/ml
0.17
17
227
17
158
1.08
0.06
1.4
1.6
0.95
0.95
g/l
0.01
17
158
19
202
0.94
0.05
1.2
2.2
2.00
2.07
u/field
—
9
81
15
161
0.93
0.05
1.2
1.3
0.62
0.94
u/ml
—
7
89
34
353
0.96
0.04
2.3
1.6
—
—
—
0
0
25
239
1.05
0.04
1.0
1.1
100.48
94.99
%
0.67
25
226
13
121
1.07
0.03
1.4
1.2
163.15
360.04
u/l
1.27
13
112
23
220
1.05
0.03
1.3
1.5
—
—
—
0
0
12
128
0.94
0.02
1.0
1.3
1.76
1.55
g/l
2.01
12
128
30
308
0.97
0.02
1.1
1.1
—
—
—
0
0
15
156
0.96
0.00
1.3
1.4
—
—
—
0
0
50
506
0.99
0.00
2.6
3.4
65.32
829.25
u/ml
0.88
45
472
11
112
0.98
0.00
11.1
11.5
0.60
0.62
mmol/l
0.09
11
103
28
282
0.99
0.00
1.5
1.4
55039.95
87135.84
e6/l
0.39
21
173
6
68
0.88
-0.00
1.2
1.3
9.83
23.67
%
—
6
55
8
82
0.98
-0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1483.00
—
0
6
11
110
1.00
-0.00
1.3
1.3
6.03
6.09
mmol/l
0.08
11
105
6
62
0.97
-0.00
1.5
2.1
5.89
8.84
mg/l
—
6
49
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
1.30
—
0
8
7
79
0.89
-0.00
1.0
1.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
95
0.95
-0.00
1.4
1.9
137.44
159.78
%
—
9
90
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_PARASTRAB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_PARASTRAB | 1.349 [1.22, 1.49] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.034 |
During the follow-up period (1.1.1998 — 31.12.2019), 1840 out of 7311 females with H7_PARASTRAB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_PARASTRAB | 1.428 [1.29, 1.58] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 2050 out of 7503 males with H7_PARASTRAB died.
Mortality risk
Mortality risk for people of age
years, who have H7_PARASTRAB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.105% | 0.282% |
| 5 | 0.75% | 1.616% |
| 10 | 1.723% | 4.105% |
| 15 | 3.265% | 8.143% |
| 20 | 5.54% | 13.415% |
Relationships between endpoints
↥Index endpoint: H7_PARASTRAB – Paralytic strabismus
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data